Attenuation of leukocyte β2-integrin expression by antithrombin-III

International Journal of Immunopathology and Pharmacology

Volumn 17, Issue 1, 2004, Pages 27-32

  Gritti, D ^a   Malinverno, A ^a   Gasparetto, C ^a   Wiedermann, C J ^b   Ricevuti, Giovanni ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Cardiopulmonary bypass; Coagulation; Inflammation; Leukocytes

Indexed keywords

ANTITHROMBIN III; BETA2 INTEGRIN; CD11B ANTIGEN; CD18 ANTIGEN; INTEGRIN; PROTEOHEPARAN SULFATE; RECOMBINANT ANTITHROMBIN III; RECOMBINANT PROTEIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATTENUATION; BLOOD CLOTTING; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; EX VIVO STUDY; EXTRACORPOREAL CIRCULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; LEUKOCYTE ACTIVATION; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADULT; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM;

ADULT; ANTIGENS, CD18; ANTITHROMBIN III; HUMANS; LEUKOCYTES; RECOMBINANT PROTEINS;

EID: 5444243424     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200401700104     Document Type: Article

References (27)

1. Koster A., T. Fischer, M. Praus, H. Haberzettl, W.M. Kuebler, R. Hetzer and H. Kuppe. 2002. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management. Anesthesiology 97:83.
2. Yeung P.K. 2000. Technology evaluation: transgenic antithrombin III (rhAT-III), Genzyme Transgenics. Curr. Opin. Mol. Ther. 2:336.
3. Slaughter T.F., J.K. Mark, H. El-Moalem, K.A. Hayward, A.K. Hilton, L.P. Hodgins and C.S. Greenberg. 2001. Hemostatic effects of antithrombin III supplementation during cardiac surgery: results of a prospective randomized investigation. Blood Coagul. Fibrinolysis 12:25.
4. Williams M.R., A.B. D'Ambra, J.R. Beck, T.B. Spanier, D.L. Morales, D.N. Helman and M.C. Oz. 2000. A randomized trial of antithrombin concentrate for treatment of heparin resistance. Ann. Thorac. Surg. 70:873.
5. Sonzogni V., P. Bellavita, B. Carrara, M. Cossolini, F. Ferri, F. Fabretti, F. Mamprin and I. Pelliccioli. 2000. The effect of antithrombin III concentrations during cardiopulmonary surgery. Minerva Anestesiol. 66:17.
6. Ernofsson M., S. Thelin and A. Siegbahn. 1997. Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study. J. Thorac. Cardiovasc. Surg. 113:576.
7. Sundaram S., F. Lim, S.L. Cooper and R.W. Colman. 1996. Role of leucocytes in coagulation induced by artificial surfaces: investigation of expression of Mac-1, granulocyte elastase release and leucocyte adhesion on modified polyurethanes. Biomaterials 17:1041.
8. Yoshimura Y., Y. Hiramatsu, Y. Sato, S. Homma, Y. Enomoto, Y. Kikuchi and Y. Sakakibara. 2003. Activated neutrophils and platelet microaggregates impede blood filterability through microchannels during simulated extracorporeal circulation. Ann. Thorac. Surg. 75:1254.
9. Gritti D., C. Gasparetto, A. Malinverno and G. Ricevuti. 2002. Inhibition of leukocyte and platelet aggregation in vitro by antithrombin. Acta Med. Austriaca 29:97.
10. Margreiter J., M. Mittermayr, J. Mair, A. Hammerer-Lercher, J. Kountchev, A. Klingler and W. Schobersberger. 2002. Influence of antithrombin on ischemia/reperfusion injury in the isolated blood-free perfused rat heart. Thromb. Res. 108:249.
11. Nishijima K., J. Kiryu, A. Tsujikawa, M. Honjo, A. Nonaka, K. Yamashiro, H. Kamizuru, Y. Ieki, H. Tanihara, Y. Honda and Y. Ogura. 2003. Inhibitory effects of antithrombin III on interactions between blood cells and endothelial cells during retinal ischemia-reperfusion injury. Invest. Ophthalmol. Vis. Sci. 44:332.
12. Ostrovsky L., R.C. Woodman, D. Payne, D. Teoh and P. Kubes. 1997. Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion. Circulation 96:2302.
13. Hoffmann J.N., B. Vollmar, J. Romisch, D. Inthorn, F.W. Schildberg and M.D. Menger. 2002. Antithrombin effects on endotoxin-induced microcirculatory disorders are mediated mainly by its interaction with microvascular endothelium. Crit. Care. Med. 30:218.
14. Mizutani A., K. Okajima, M. Uchiba, H. Isobe, N. Harada, S. Mizutani and T. Noguchi. 2003. Antithrombin reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation through promotion of prostacyclin production. Blood 101:3029.
15. Woodman R.C., L. Ostrovsky, D. Teoh, D. Payne, M.C. Poon and P. Kubes. 1998. Antithrombin and ischemia/reperfusion. Blood. Coagul. Fibrinolysis 9(S): S7.
16. Hoffmann J.N., B. Vollmar, M.W. Laschke, D. Inthorn, N.C. Kaneider, S. Dunzendorfer, C.J. Wiedermann, J. Romisch, F.W. Schildberg and M.D. Menger. 2002. Adverse effect of heparin on antithrombin action during endotoxemia: microhemodynamic and cellular mechanisms. Thromb. Haemost. 88:242.
17. Kaneider N.C., A. Djanani, R. Fischer-Colbrie and C.J. Wiedermann. 2002, Sphingosine kinase-dependent directional migration of leukocytes in response to phorbol ester. Biochem. Biophys. Res. Commun. 297:806.
18. Kaneider N.C., C.M. Reinisch, S. Dunzendorfer, J. Romisch and C.J. Wiedermann. 2002. Syndecan-4 mediates antithrombin-induced chemotaxis of human peripheral blood lymphocytes and monocytes. J. Cell. Sci. 115:227.
19. Kaneider N.C., P. Egger, S. Dunzendorfer and C.J. Wiedermann. 2001. Syndecan-4 as antithrombin receptor of human neutrophils. Biochem. Biophys. Res. Commun. 287:42.
20. Dunzendorfer S., N.C. Kaneider, A. Rabensteiner, C. Meierhofer, C. Reinisch, J. Romisch and C.J. Wiedermann. 2001. Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III. Blood 97:1079.
21. Witko-Sarsat V., P. Rieu, B. Descamps-Latscha, P. Lesavre and L. Halbwachs-Mecarelli. 2000. Neutrophils: molecules, functions and pathophysiological aspects. Lab. Invest. 80:617.
22. Lekstrom-Himes J.A. and J.I. Gallin. 2000. Immunodeficiency diseases caused by defects in phagocytes. N. Engl. J. Med. 343:1703.
23. Kaneider N.C., A. Kaser, H. Tilg, G. Ricevuti and C.J. Wiedermann. 2003. CD40 ligand-dependent maturation of human monocyte-derived dendritic cells by activated platelets. Int. J. Immunopathol. Pharmacol. 16:225.
24. Carden D.L. and D.N.Granger. 2000. Pathophysiology of ischaemia-reperfusion injury. J. Pathol. 190:255.
25. Gerard C. and N.P. Gerard. 1994. The pro-inflammatory seven-trans-membrane segment receptors of the leukocyte. Curr. Opin. Immunol. 6:140.
26. Roemisch J., E. Gray, J.N. Hoffmann and C.J. Wiedermann. 2002. Antithrombin: a new look at the actions of a serine protease inhibitor. Blood Coagul. Fibrinolysis 13:657.
27. Ranucci M. 2002. Antithrombin III. Key factor in extracorporeal circulation. Minerva Anestesiol. 68:454.